Visualizing Digital Endpoints: Tools and Techniques for Modern Trials

Introduction: Why Visualization Matters in Digital Trials

The rise of wearable sensors, ePROs, and mobile apps in clinical trials has led to an explosion of data—continuous, high-frequency, and multidimensional. While this information is rich in clinical potential, it remains useless without effective visualization.

Data visualization tools convert raw digital endpoints into intuitive charts, graphs, and dashboards that enable sponsors, investigators, and regulators to spot trends, outliers, and meaningful change. This tutorial explores the most widely used tools, visualization methods, and real-world best practices in the pharma and CRO space.

Common Visualization Types for Digital Endpoints

Visualizing digital endpoints requires different approaches compared to traditional lab or CRF data. Common visual elements include:

• Time-Series Line Charts: Ideal for continuous data like HR, SpO2, or steps per hour
• Heatmaps: Useful for representing activity, sleep, or sensor compliance across time
• Box-and-Whisker Plots: For visualizing distribution and variability across subjects
• Overlay Plots: Allow comparison of baseline vs treatment phase data
• Sparklines: Condensed line charts embedded into tabular views for trend scanning

Example:

Subject	Day 1	Day 2	Day 3	Trend
101	5600	6300	5900
102	7200	6800	6400

Popular Tools for Wearable Data Visualization

Several commercial and open-source platforms are used in trials today:

• Tableau: Preferred for interactive dashboards; supports large datasets and time-series plots
• Power BI: Easy to integrate with EDC or data lakes for daily refresh of trial metrics
• Python (Plotly/Seaborn/Matplotlib): Ideal for customized visualizations in statistical programming workflows
• R (Shiny, ggplot2): Extensively used in bioinformatics and CRO biometrics teams
• Medidata Rave Visualizations: Built-in tools for regulated digital endpoint review

For GxP use, visualization modules must be validated, with audit trails and version control.

Regulatory Expectations for Visual Data Submissions

When submitting visualizations to agencies, ensure they are:

• Traceable: All plots should be linked to SDTM/ADaM datasets with reproducible scripts
• Annotated: Axes, legends, units, and transformations must be clearly labeled
• Static and Archivable: For formal submission, PDF or TIFF versions are required
• Version Controlled: Graphs must reflect final, locked datasets with date stamps

Agencies like FDA and EMA expect transparency in data derivation and visualization workflows.

Dashboard Design for Sponsor Oversight and Site Engagement

Dashboards consolidate multiple digital endpoints into unified views for different stakeholders:

• Executive Dashboards: Aggregate metrics like device compliance, data completeness, alert counts
• Site Dashboards: Focused views showing individual subject adherence and safety flags
• Data Monitoring Dashboards: Allow biostatisticians and DMCs to view de-identified trends in real time

Best practices include role-based access, color-blind friendly palettes, and interactive filters (e.g., by visit, site, or device type).

For example, a dashboard in a COPD trial showed step count quartiles with thresholds to flag sedentary drift or exacerbation.

Visualizing Subject-Level Trajectories and Alerts

Subject-level data is critical to monitor adherence, progression, or adverse trends. Visualization techniques include:

• Patient Timelines: Plotting wearable data alongside dosing, AE, and diary entries
• Delta Plots: Highlight changes from baseline per patient
• Rolling Average Bands: Smoothed plots with confidence intervals
• Alert Markers: Auto-generated flags for threshold breaches

CROs can use these plots during SDV or query reconciliation, improving patient-level data understanding.

Integrating Visualizations into CRO Biometrics Workflows

CROs typically adopt visualization early in the data pipeline. Example workflow:

1. Raw wearable data ingested and stored in data lake
2. R/Python scripts clean and aggregate digital endpoints (e.g., daily avg HR)
3. SDTM/ADaM datasets generated and linked to graphs via Plotly dashboards
4. Statisticians use visuals during interim analysis and DSMB reviews

Toolchains must comply with 21 CFR Part 11 and include e-signature workflows for visual output approval.

Visit PharmaSOP for visualization SOP templates tailored for CRO teams.

Case Study: Visualization in a Digital Endpoint Oncology Trial

A Phase II decentralized oncology trial used wrist-worn sensors to monitor fatigue and physical function.

• Heatmaps tracked daily step count and sleep hours across 200 subjects
• Boxplots visualized intra-subject variation vs inter-subject variability
• Interactive plots identified a subset of patients with unexpected activity spikes
• Findings led to updated ePRO reminders and improved adherence by 14%

Visual tools were instrumental in protocol optimization mid-study.

Choosing the Right Visualization Strategy

Select visualization methods based on endpoint type, audience, and regulatory pathway:

Conclusion: From Data to Decisions

Effective visualization is not just an aesthetic layer—it’s a decision-enabling tool in modern trials. Whether tracking wearables, ePROs, or digital biomarkers, the ability to visually interpret data accelerates insights, boosts oversight, and supports regulatory submissions.

With growing volumes of sensor and real-time data, CROs and sponsors must build visualization capabilities into their biometrics infrastructure, ensuring clarity, compliance, and confidence at every step.